Efficacy of low dose of rituximab to treat systemic lupus erythematosus
By
Yan Chen
Limei Xu
Yanqing Wang
Xuwei Yang
Wenzhong Que
June 16, 2026
Clinical Scorecard: Effectiveness of Low-Dose Rituximab in the Management of Systemic Lupus Erythematosus
At a Glance
Category Detail
Condition Key Mechanisms Remove unsupported claims or provide direct citations. Target Population Care Setting
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
E n s u r e r e c o m m e n d a t i o n s a r e d i r e c t l y s o u r c e d f r o m t h e s t u d y o r g u i d e l i n e s . Monitoring & Follow-up
Risks
Patient & Prescribing Data
117 SLE patients analyzed, with 51 receiving low-dose RTX and 66 receiving BEL.
Low-dose RTX achieved an overall efficacy of 39.2% compared to 57.6% for BEL.
Clinical Best Practices
Related Resources & Content
